350
Participants
Start Date
June 26, 2023
Primary Completion Date
September 30, 2025
Study Completion Date
March 31, 2026
Latent class analysis
"The investigators will conduct a longitudinal study comprising nested groups A to C of the study population, with progressively more detailed mechanistic investigations. No control group.~Group A will complete a CF-specific measure of gut symptoms (CFAbd-Score), a generic constipation score (PAC-SYM) and 24 hour dietary recall (Intake24).~Group B will have stool and blood for microbiome, inflammatory mediators and faecal fat.~Group C will have gut MRI and exploratory studies of inflammation."
RECRUITING
Nottingham University Hospitals Trust, Nottingham
Collaborators (1)
Cystic Fibrosis Trust
OTHER
Motilent
UNKNOWN
Nottingham Trent University
OTHER
Vanderbilt University Medical Center
OTHER
University of Leeds
OTHER
Brandenburg Medical School Theodor Fontane
OTHER
University of Glasgow
OTHER
National Institute for Health Research, United Kingdom
OTHER_GOV
University of Birmingham
OTHER
Northumbria University
OTHER
Imperial College London
OTHER
University of Nottingham
OTHER